A non-extracting procedure for the determination of meloxicam in plasma samples by HPLC-DIODE Array Detection

Arzneimittel-Forschung/Drug Research

Volumn 55, Issue 6, 2005, Pages 326-331

  Medvedovici, Andrei ^a   Albu, Florin ^b   Georgita, Cristina ^b   Mircioiu, Constantin ^c   David, Victor ^a  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b LaborMed Pharma SA   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Anti inflammatory drugs, non steroidal; CAS 36322 90 4; CAS 71125 38 7; Meloxicam, bioequivalence study, detection in plasma, non extractive HPLC DAD method; Piroxicam

Indexed keywords

MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIODE ARRAY DETECTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLASMA; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION;

EID: 21244473075     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296867     Document Type: Article

References (8)

1. Tsubouchi, Y., Sano, H., Yamada, et al., Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes. Eur. J. Pharmacol. 395, 255 (2000)
2. Bednarek, D., Zdzisinska, B., Kondracki, M. et al., Effect of steroidal and non-steroidal anti-inflammatory drugs in combination with long-acting oxytetracycline on non-specific immunity of calves suffering from enzootic bronchopneumonia. Veterinary Microbiol. 96, 53 (2003)
3. Velpandian, T., Jaiswal, J., Bhardwaj, R. K. et al., Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples. J. Chromatogr. B 738, 431 (2000)
4. Elbary, A. A., Foda, N., Elkhateeb, M., Reversed phase liquid chromatographic determination of meloxicam in human plasma and its pharmacokinetic application. Anal. Lett. 34, 1175 (2001)
5. Dasandi, B., Saroj, S. H., Bhat, K. M., LC determination and pharmacokinetics of meloxicam. J. Pharm. Biomed. Anal. 28, 999 (2002)
6. Wiesner, J. L., de Jager, A. D., Sutherland, F. C. W. et al., Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of meloxicam in human plasma. J. Chromatogr. B 785, 115 (2003)
7. David, V., Albu, F., Medvedovici, A., Retention-structure correlation of some oxicam drugs in reversed-phase liquid chromatography. J. Liq. Chromatogr. Rel. Technol. 27, 951 (2004)
8. Lovin, I., Albu, F., Tache, F. et al., Solvent and solvents effects on sample preparation for the determination of fenofibric acid in human plasma by HPLC-DAD. Microchem. J. 75, 179 (2003)